Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tiffany L. Beck"'
Autor:
Tiffany L. Beck, Hitomi Momose, Jeffrey M. Dym, Vikas Y. Rao, Randy Bohart, Bram H. Goldstein
Publikováno v:
Gynecologic Oncology Reports, Vol 29, Iss , Pp 55-57 (2019)
Dysgerminomas are aggressive germ cell tumors that typically have a favorable prognosis, especially in patients diagnosed with early stage disease. We recount the history of a 23-year-old woman who was treated for a stage IA ovarian dysgerminoma in N
Externí odkaz:
https://doaj.org/article/58620e66db5d4212a45e64eacf3046bf
Publikováno v:
Journal of Minimally Invasive Gynecology. 25:986-993
To compare patient outcomes by surgical approach in the management of endometrial cancer (EC) in Washington State from 2008 to 2013.Population-based retrospective cohort study (Canadian Task Force classification II-2).Washington State.EC patients tre
Autor:
Tiffany L. Beck, John V. Brown, Bram H. Goldstein, Alberto A. Mendivil, Howard D. Epstein, Lisa N. Abaid, Kristina M. Mori, John P. Micha
Publikováno v:
International Journal of Surgery. 53:239-242
Introduction When the Food and Drug Administration (FDA) initially reported on the parlous incidence (0.28%) of occult malignancy identified following uterine power morcellation, investigations thereafter documented their particular experience with t
Autor:
Kristina M. Mori, Bram H. Goldstein, Alberto A. Mendivil, Howard D. Epstein, John P. Micha, Tiffany L. Beck, John V. Brown, Lisa N. Abaid
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 224:29-32
Objectives The purpose of this study was to report on the feasibility of laparoscopic sentinel lymph node (SLN) staging using indocyanine green (ICG) in the management of endometrial cancer. Study design We retrospectively evaluated the charts of pre
Autor:
Jeffrey M. Dym, Bram H. Goldstein, Vikas Y. Rao, Tiffany L. Beck, Hitomi Momose, Randy Bohart
Publikováno v:
Gynecologic Oncology Reports
Gynecologic Oncology Reports, Vol 29, Iss, Pp 55-57 (2019)
Gynecologic Oncology Reports, Vol 29, Iss, Pp 55-57 (2019)
Dysgerminomas are aggressive germ cell tumors that typically have a favorable prognosis, especially in patients diagnosed with early stage disease. We recount the history of a 23-year-old woman who was treated for a stage IA ovarian dysgerminoma in N
Autor:
Tiffany L. Beck, Paniti Sukumvanich, Alexander B. Olawaiye, Joseph L. Kelley, John T. Comerci, Sushil Beriwal, Robert P. Edwards, J.F. Lin, R. Marshall Austin, Miao Crystal Yu
Publikováno v:
Archives of Pathology & Laboratory Medicine. 139:1437-1440
Context Cervical cancer affects 12 000 women in the United States annually. However, despite its prevalence, there remains no good methodology to detect its recurrence. Objective To identify the role of cervicovaginal high-risk human papilloma virus
Autor:
John B. Liao, Chirag A. Shah, Dan S. Veljovich, Pam Paley, Nadia V. Giannakopoulos, Tiffany L. Beck
Publikováno v:
Journal of Gynecologic Oncology
OBJECTIVE The use of robotic radical hysterectomy has greatly increased in the treatment of early stage cervical cancer. We sought to compare surgical and oncologic outcomes of women undergoing robotic radical hysterectomy compared to open radical hy
Autor:
Pankaj Singhal, Shashikant Lele, William C. McBee, Tiffany L. Beck, Thomas C. Krivak, Hugh M. Ehrenberg, Peter G. Rose
Publikováno v:
Gynecologic Oncology. 125:141-144
Objective Endometrial stromal sarcoma (ESS) is a rare and indolent form of uterine cancer with ill-defined post-operative treatment guidelines. The goal of this study was to evaluate the rate of recurrence and the effect of various adjuvant treatment
Autor:
Renata R. Urban, Barbara A. Goff, Tiffany L. Beck, Christopher B. Morse, John B. Liao, Heidi J. Gray
Publikováno v:
American journal of obstetrics and gynecology. 214(3)
Recent policy changes by insurance companies have been instituted to encourage vaginal hysterectomy (VH) as the preferred route for removal of the uterus. It is not known if advantages of VH for benign indications apply to women with gynecologic canc
Autor:
Joseph L. Kelley, Tiffany L. Beck, Thomas C. Krivak, Kristin K. Zorn, Sarah Taylor, Robert P. Edwards
Publikováno v:
Gynecologic oncology. 134(1)
Objective Hypersensitivity reactions can preclude platinum re-challenge for patients receiving second-line and higher carboplatin/cisplatin salvage therapy. The objective is to report our patient experience with oxaliplatin in recurrent or progressiv